GODAVARI DRUGS LTD. (GODAVARI)

BSE: ₹122.50
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find the enclosed newspaper publication for your information

2026-05-28 12:07:11
Financial Results For Period Ended 31St March,2026

Company in its Board Meeting has approved financial results for period ended 31st march, 2026

2026-05-27 16:53:20
Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday 27Th Day Of May,2026

We are enclosing Audited Financial Results for the Quarter ended 31st march , 2026 which are approved in Board Meeting which was held today i.e Wednesday, 27th Day of May, 2026

2026-05-27 16:47:51
Board Meeting Intimation for Board Meeting Intimation For The Fourth Quarter And Financial Year Ended March 31, 2026

the financial results for the fourth quarter and financial year ended March 31, 2026.

2026-05-22 13:41:05
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the year ended 31st March, 2026

2026-05-20 10:10:07
Clarification On Price Movement

Reply to the BSE Query seeking Clarification on Price Movement

2026-04-18 15:34:57
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find enclosed herewith intimation under Regulation 74(5) of SEBI (DP) Regulations, 2015 for quarter ended March, 2026

2026-04-08 16:05:44

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 35.42 39.54 43.11 38.64 32.21 26.09 29.55 25.50 23.81 26.65 22.18 33.16
YOY Revenue Growth % -16.76% -2.48% 10.09% 3.4% -9.07% -34.03% -31.45% -34% -26.07% 2.15% -24.93% 30.04%
Other Income 0.45 0.00 0.05 0.11 0.77 0.01 0.10 0.11 0.01 0.64 0.02 0.14
Total Income 35.87 39.55 43.16 38.75 32.97 26.10 29.65 25.61 23.82 27.28 22.20 33.30
Total Expenses + 34.75 38.27 41.36 35.93 30.96 24.85 28.73 24.17 22.52 26.16 21.43 31.79
Cost of Materials Consumed 26.44 30.35 32.95 32.20 26.95 16.98 19.59 21.73 17.99 23.99 16.64 30.27
Employee Benefit Expense 1.22 1.19 1.27 1.45 1.26 1.38 0.98 1.40 1.36 1.44 1.58 1.32
Other Expenses 3.88 4.53 3.99 5.06 4.30 4.24 2.90 3.39 2.42 3.10 3.25 3.53
Operating Profit 0.67 1.27 1.75 2.71 1.25 1.24 0.82 1.33 1.29 0.49 0.75 1.37
OPM % 1.9% 3.2% 4.1% 7% 3.9% 4.8% 2.8% 5.2% 5.4% 1.8% 3.4% 4.1%
Profit Before Tax + 1.12 1.27 1.74 2.79 2.01 1.25 0.92 1.44 1.30 1.12 1.02 1.62
Tax Expense 0.31 0.42 0.52 0.13 0.38 0.16 0.15 0.55 0.26 0.12 0.26 0.33
Tax % 27.5% 32.8% 29.9% 4.6% 19% 13.1% 16.7% 38% 20.1% 10.8% 25.9% 20.2%
Profit After Tax 0.81 0.86 1.22 2.66 1.63 1.09 0.77 0.89 1.04 1.00 0.76 1.29
EPS (Basic) 1.08 1.14 1.62 3.53 2.17 1.45 1.02 1.19 1.38 1.33 1.01 1.71

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 105.81 113.35 156.71 159.62 161.11 122.67
YOY Revenue Growth % -6.65% -27.67% -1.82% -0.92% 31.33% -
Other Income 0.81 0.98 0.62 0.66 0.28 0.41
Total Income 106.61 114.33 157.33 160.28 161.38 123.08
Total Expenses + 101.91 108.70 150.32 155.57 154.36 117.37
Cost of Materials Consumed 88.89 85.24 121.95 137.82 127.97 94.15
Employee Benefit Expense 5.70 5.03 5.13 4.84 4.96 3.94
Other Expenses 12.30 14.84 17.47 16.81 14.40 12.31
Operating Profit 3.90 4.65 6.39 4.05 6.74 5.30
OPM % 3.7% 4.1% 4.1% 2.5% 4.2% 4.3%
Profit Before Exceptional 4.71 5.63 7.01 4.71 7.02 5.71
Exceptional Items 0.36 0.00 -0.09 0.23 0.00 0.00
Profit Before Tax + 5.06 5.63 6.92 4.93 7.02 5.71
Tax Expense 0.97 1.25 1.37 1.15 1.78 1.58
Tax % 19.2% 22.1% 19.8% 23.3% 25.3% 27.7%
Profit After Tax 4.09 4.38 5.55 3.79 5.25 4.13
EPS (Basic) 5.43 5.82 7.37 5.03 6.97 5.48

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 88.63 64.31 46.27 34.43 27.08 23.53
Property, Plant & Equipment 30.31 32.61 26.68 24.91 26.25 22.43
Capital Work in Progress 56.54 29.95 18.32 9.08 0.49 0.76
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 111.80 78.76 88.48 87.00 74.33 67.61
Inventories 46.06 27.94 20.65 19.86 10.03 14.65
Trade Receivables 43.58 42.32 59.42 57.93 55.58 45.12
Cash and Cash Equivalents 14.51 2.37 2.62 3.08 2.28 1.64
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 75.80 43.35 38.97 33.42 29.63 24.39
Equity Share Capital 10.13 7.53 7.53 7.53 7.53 7.53
Other Equity 65.67 35.82 31.44 25.89 22.10 16.86
Non-Current Liabilities 39.49 26.64 13.79 14.31 14.02 16.24
Current Liabilities 85.14 73.09 82.00 73.71 57.76 50.51
Total Liabilities 124.63 99.73 95.79 88.02 71.78 66.75

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 0.73 11.20 18.41 13.22 11.23 1.33
Cash from Investing Activities -25.95 -19.51 -13.22 -8.64 -4.97 -1.25
Cash from Financing Activities 37.35 8.07 -5.65 -3.77 -5.62 0.13
Net Increase/Decrease in Cash 12.14 -0.25 -0.46 0.81 0.64 0.21